Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (45)
  • 2024 (26)
  • 2023 (47)
  • 2022 (136)
  • 2021 (162)
  • 2020 (53)
  • 2019 (75)
  • 2018 (41)
  • 2017 (37)
  • 2016 (47)
  • 2015 (42)
  • 2014 (54)
  • 2013 (64)
  • 2012 (18)
  • 2011 (67)
  • 2008 (10)
  • 2007 (18)
  • 2006 (23)
  • 2005 (15)
  • 2004 (13)
  • 2003 (23)

Subject

  • Drug Trafficking (240)
  • Synthetic drugs (190)
  • Seizures (Drugs/Property) (184)
  • Task Forces/Task Force Officers (168)
  • Major Law Enforcement Operation (137)
  • Guns/Weapons (103)
  • OCDETF/Task Force (86)
  • Overdose (71)
  • Arrests/Convictions - Major (67)
  • Prescription Drugs (66)
  • Fake Pills (63)
  • Gangs (51)
  • Outreach/Drug Prevention (49)
  • Pharmaceuticals/Pharmacists/Physicians (44)
  • Diversion Division (42)
  • Narcoterrorism (41)
  • Take Back Day (36)
  • Press Conferences (32)
  • Guilty Plea (31)
  • Public and Media Affairs - also see Congressional Affairs (26)
  • Money Laundering (23)
  • One Pill Can Kill (18)
  • Fentanyl Awareness (17)
  • Prevention/Education - DEA websites GSAD, JTT etc (15)
  • Congressional Affairs (12)
  • HIDTA (10)
  • International/Foreign Operations (10)
  • Red Ribbon (9)
  • Dark Web- Internet Trafficking (8)
  • Extraditions (7)
  • Intergovernmental Affairs (6)
  • Asset Forfeiture (5)
  • Critical Incident (3)
  • Museum and Visitors Center (3)
  • Terrorism (3)
  • Fentanyl Free America (2)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • Other (1)

Drug Name

  • Fentanyl (195)
  • Cocaine (138)
  • Heroin (107)
  • Synthetic Opioids (89)
  • Methamphetamine (73)
  • Opioids (60)
  • Oxycodone (28)
  • Marijuana (Cannabis) (21)
  • Hydromorphone (7)
  • Benzodiazepines (6)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • K2/Spice (4)
  • Steroids (4)
  • Marijuana Concentrates (3)
  • Ketamine (2)
  • Methadone (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Amphetamines (1)
  • GHB (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • New England (2349)
  • New York (1519)
  • Houston (893)
  • San Francisco (842)
  • Miami (825)
  • St. Louis (808)
  • Seattle (801)
  • Atlanta (763)
  • Chicago (622)
  • New Jersey (493)
  • New Orleans (470)
  • Detroit (360)
  • El Paso (346)
  • Dallas (315)
  • Los Angeles (299)
  • Phoenix (271)
  • San Diego (244)
  • Rocky Mountain (165)
  • Philadelphia (140)
  • Omaha (134)
  • Caribe (79)
  • Louisville (77)
  • Caribe (1)
  • Washington, DC (613)
  • Sede (408)
Clear All Results
PRESS RELEASE

DEA Meets With Pharmaceutical Industry Leaders Today To Discuss Collaboratively Preventing Prescription Drug Misuse And Abuse

Febrero 29, 2016
WASHINGTON - U.S. Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and the Chief of DEA’s Office of Diversion Control, Lou Milione hosted a meeting today in Washington with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical...
Febrero 29, 2016
PRESS RELEASE

DEA Reaches $8 Million Settlement Agreement With CVS For Unlawful Distribution Of Controlled Substances

Febrero 12, 2016
BALTIMORE - CVS Pharmacy, Inc. (CVS) has agreed to pay $8 million to the United States to resolve allegations that its Maryland pharmacies violated the Controlled Substances (CSA) by dispensing controlled substances pursuant to prescriptions that were not issued for a legitimate medical purpose. The settlement agreement was announced today...
Febrero 12, 2016
PRESS RELEASE

Philadelphia Attorney Indicted In Maryland For Conspiring To Launder Drug Proceeds Involving A Major Drug Distribution Organization

Febrero 12, 2016
GREENBELT, Md. - Philadelphia attorney James Michael Farrell, age 63, of Wenonah, New Jersey, had his initial appearance and arraignment today in U.S. District Court in Greenbelt, Maryland, on charges related to his activities on behalf of members of an extensive drug trafficking operation. Mr. Farrell pleaded not guilty to...
Febrero 12, 2016
PRESS RELEASE

Bowie Drug Trafficker Convicted For $108 Million Drug Distribution And Money Laundering Conspiracies

Febrero 10, 2016
GREENBELT, Md. - A federal jury today convicted Andracos Marshall, a/k/a “Draco,” 41, of Bowie, Maryland, for conspiracy to distribute cocaine, possession with intent to distribute cocaine, and for money laundering conspiracy. The conviction was announced by Special Agent in Charge Karl C. Colder of the Drug Enforcement Administration -...
Febrero 10, 2016
PRESS RELEASE

DEA Administrator Chuck Rosenberg Statement On Walgreens’ Prescription Drug Take Back Initiative

Febrero 09, 2016
WASHINGTON - The United States Drug Enforcement (DEA) commends Walgreens for their commitment to install secure collection bins for unused prescription drugs in over 500 of their stores in 40 states. "Take back programs are an important and easy way for the public to anonymously dispose of their unwanted, unused...
Febrero 09, 2016
PRESS RELEASE

FBI, DEA Release Documentary Film Addressing Heroin/Prescription Drug Abuse

Febrero 04, 2016
WASHINGTON - In an effort to combat the growing epidemic of prescription drug and heroin abuse, leaders of the FBI and DEA today unveiled a documentary aimed at educating students and young adults about the dangers of the addiction. “Chasing the Dragon” is a 45-minute documentary film that profiles the...
Febrero 04, 2016
PRESS RELEASE

DEA And European Authorities Uncover Massive Hizballah Drug And Money Laundering Scheme

Febrero 01, 2016
WASHINGTON - The United States Drug Enforcement (DEA) today announced significant enforcement activity including arrests targeting Lebanese Hizballah’s External Security Organization Business Affairs (BAC), which is involved in international criminal activities such as drug trafficking and drug proceed money laundering. These proceeds are used to purchase weapons for Hizballah for...
Febrero 01, 2016
PRESS RELEASE

Previously Convicted Felon Sentenced On Drug Charges And Firearm Possession

Enero 28, 2016
GREENBELT, Md. - U.S. District Judge Theodore D. Chuang sentenced Charles Brian Curtin, 46, of Mechanicsville, Maryland today to 200 months in prison, followed by five years of supervised release, for conspiracy to distribute and possess with intent to distribute cocaine, and for being a felon in possession of a...
Enero 28, 2016
PRESS RELEASE

DEA Statement On The Capture Of Joaquin “Chapo” Guzman-Loera

Enero 08, 2016
WASHINGTON - The capture of Joaquin “Chapo” Guzman-Loera is a victory for the rule of law and the Mexican people and government. The arrest is a significant achievement in our shared fight against transnational organized crime, violence, and drug trafficking. It is further evidence of our two countries’ resolve to...
Enero 08, 2016
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

Diciembre 23, 2015
WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...
Diciembre 23, 2015
Showing 661 - 670 of 1016 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 63
  • Página 64
  • Página 65
  • Página 66
  • Current page 67
  • Página 68
  • Página 69
  • Página 70
  • Página 71
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster